Race and socioeconomic status in pediatric allogeneic hematopoietic cell transplantation for nonmalignant conditions
- 1 September 2020
- journal article
- research article
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 67 (9), e28367
- https://doi.org/10.1002/pbc.28367
Abstract
Background Survival disparities by race/ethnicity and socioeconomic status (SES) are observed in a wide range of pediatric treatment settings including oncology and solid organ transplantation. To date, few studies have examined the effects of race and SES on outcomes in pediatric allogeneic hematopoietic cell transplantation (HCT). We explored whether survival differed by race/ethnicity or SES in children receiving HCT for nonmalignant conditions at a single institution serving a diverse patient population. Procedures The Kaplan-Meier method was used to estimate overall survival (OS) with the log-rank test for between-group comparisons. Cox proportional hazards models were used to identify risk factors for OS, adjusting for treatment- and disease-related factors. Results Of 133 subjects, 0 to 21 years, 19% were non-Hispanic (NH) white, 34% were NH black, 40% were Hispanic, and 7% were Asian. Sixty-seven percent of the subjects had public insurance; 49% lived in neighborhoods with poverty rate >= 20%. Primary diagnoses included hemoglobinopathies (56%), bone marrow failure (22%), and other conditions (22%). Median follow-up was 5.8 years (range 0.1-14.5). Analysis revealed no difference in OS by race, insurance type, or neighborhood SES. Conclusions Findings from this single-institution study suggest that in pediatric patients undergoing HCT for nonmalignant conditions, treatment at a tertiary care center with a multidisciplinary approach may mitigate drivers of disparities observed in other settings. Additional studies are now needed to further elucidate the complex interrelationships among race, SES, and clinical outcomes for children undergoing HCT.Funding Information
- Irving Institute for Clinical and Translational Research at Columbia University Irving Medical Center
This publication has 30 references indexed in Scilit:
- Advancement of Pediatric Blood and Marrow Transplantation Research in North America: Priorities of the Pediatric Blood and Marrow Transplant ConsortiumTransplantation and Cellular Therapy, 2010
- Association of Race and Socioeconomic Position with Outcomes in Pediatric Heart Transplant RecipientsAmerican Journal of Transplantation, 2010
- Access to hematopoietic stem cell transplantationCancer, 2010
- Health disparities across the lifespan: Meaning, methods, and mechanismsAnnals of the New York Academy of Sciences, 2010
- Race and Socioeconomic Status Influence Outcomes of Unrelated Donor Hematopoietic Cell TransplantationTransplantation and Cellular Therapy, 2009
- Graft-versus-host diseaseThe Lancet, 2009
- Comparing Individual- and Area-based Socioeconomic Measures for the Surveillance of Health Disparities: A Multilevel Analysis of Massachusetts Births, 1989–1991American Journal of Epidemiology, 2006
- Effects of race on survival after stem cell transplantationTransplantation and Cellular Therapy, 2005
- Trends in Survival Rates After Allogeneic Hematopoietic Stem-Cell Transplantation for Acute and Chronic Leukemia by Ethnicity in the United States and CanadaJournal of Clinical Oncology, 2003
- CLINICAL MANIFESTATIONS OF GRAFT-VERSUS-HOST DISEASE IN HUMAN RECIPIENTS OF MARROW FROM HL-A-MATCHED SIBLING DONOR,STransplantation, 1974